1.01Introduction and Program Description
The Department of Health, Division of Behavioral Health, is requesting proposals from eligible applicants to provide Positive Pathways for Alaska Recovery: Expanding Contingency Management services for the State of Alaska in FY2026 through FY2027. Program Services are authorized under 7 AAC 78 Grant Programs. Additional governing statutes are 7AAC 78 - Grant Programs, AS 47.30.475 Grant-in-Aid Program, AS 47.30.520-620 Community Mental Health Services Act, AS 47.30.655-.915, 7AAC 70 Behavioral Health Services, 7AAC 135 Medicaid Coverage for Behavioral Health Services, AS 47.37 Uniform Alcoholism and Intoxication Treatment Act, 7 AAC 10.930 Request for a Variance, 7 AAC 138 1115 Substance Use Disorder Waiver Services, 7 AAC 139 Behavioral Health 1115 Waiver Services. State of Alaska statutes and regulations are accessible at the Department of Law Document Library or through the contact person identified on the cover page of this Request for Proposals (RFP).
The State of Alaska, through the Department of Health’s Division of Behavioral Health, invites proposals from eligible applicants to deliver Positive Pathways for Alaska Recovery: Expanding Contingency Management services for FY2026 through FY2027. In response to the escalating crisis of stimulant and opioid use disorders and the disproportionate impact on high-need, underserved communities, this program is designed to expand evidence-based Contingency Management (CM) interventions statewide. Contingency Management is defined by Substance Abuse and Mental Health Services Administration (SAMHSA) as a behavioral intervention that provides immediate, tangible rewards when a person demonstrates a verified positive behavior, such as a negative drug test or consistent attendance, to reinforce and support behavior change.
Building on the proven effectiveness of CM in promoting abstinence, enhancing treatment engagement, and reducing overdose fatalities, this initiative leverages a comprehensive implementation model that includes:
Robust Technical Assistance: Technical assistance will be provided in partnership with the University of Washington (UW) and the University of Alaska Anchorage (UAA). UW will lead training, coaching, and fidelity monitoring to ensure alignment with SAMHSA’s guidance, while UAA will support agency readiness, pre-planning, program evaluation, and over time provide training to sustain implementation.
Enhanced Incentive Structure: In alignment with the updated guidelines from the Substance Abuse and Mental Health Services Administration (SAMHSA), the allowable annual incentive per client has been increased from $75 to $750. This change aims to provide more substantial reinforcement for verified recovery behaviors, including abstinence, treatment attendance, and medication adherence.
Integrated and Sustainable Service Delivery: Proposals must demonstrate an ability to integrate CM within existing treatment frameworks while ensuring long-term sustainability through dedicated staffing (e.g., a designated .07-.10 FTE for program oversight) and data-driven evaluation practices.
This Request for Proposals (RFP) calls for innovative, high-fidelity implementations of CM that are tailored to the unique needs of Alaska’s diverse populations. The program seeks to not only address immediate treatment gaps but also establish a replicable model for enduring improvements in behavioral health outcomes across the state.
1.02Program Goals and Anticipated Outcomes
The proposed project must demonstrate a thorough understanding and support of the grant program goals and outcomes anticipated by the Department.
The Positive Pathways for Alaska Recovery: Expanding Contingency Management (CM) program is designed to expand the availability of CM services across Alaska by equipping treatment agencies with the training, tools, and oversight needed to implement CM with fidelity. The program aims to increase treatment engagement, reduce stimulant and co-occurring substance use, and ultimately lower overdose deaths through the use of evidence-based CM interventions. CM will be integrated into four treatment programs and will provide immediate, tangible rewards for verified behavioral improvements such as abstinence, consistent treatment attendance, and medication adherence. Key anticipated outcomes include:
- Strengthened internal capacity for sustainable CM delivery: Participating agencies will develop the internal structures needed to implement CM effectively. This includes establishing staffing roles, workflows, policies, procedures, and documentation practices that support CM integration and long-term sustainability within existing treatment models.
- Evaluation readiness and enhanced workforce competence: Agencies will build capacity to participate in required evaluation activities by developing reliable data collection and reporting processes. Staff will complete CM training and demonstrate the ability to deliver CM with fidelity using evidence-based tools approved by the Division.
- Improved treatment adherence and retention: As CM is implemented, agencies will demonstrate measurable improvement in client adherence to scheduled services and overall retention in care during the first year of CM service delivery.
- Reduced stimulant use and improved clinical outcomes: Clients participating in CM-supported services will demonstrate reductions in stimulant use and increased treatment completion rates, contributing to improved long-term recovery outcomes.
Projects must meet or exceed anticipated minimum outcomes described in this RFP.
1.03Program Services/Activities
The Positive Pathways for Alaska Recovery (PPAR) initiative is designed to support the integration of Contingency Management (CM) into participating treatment programs using a phased, evidence-informed approach. The program emphasizes high-fidelity implementation and long-term sustainability through a structured sequence of activities that includes initial planning and staff training, launch of CM services, continued technical assistance and fidelity monitoring, evaluation and reporting, and sustainability planning to support continuation beyond the grant period.
Applicants must clearly describe how the proposed project will implement CM services consistent with the purpose and intent of this grant program. Projects must demonstrate the capacity to integrate evidence-based CM practices into existing treatment models and to participate fully in required training, evaluation, oversight, and sustainability activities.
Track Structure and Technical Assistance
The program includes two participation tracks based on agency readiness: the Implementation-Ready Track and the Readiness Development Track. Track assignment determines the type and level of technical assistance an agency will receive. Track selection does not affect the amount of funding awarded. All funded agencies will receive the same award amount regardless of track.
Technical assistance will be delivered through existing contracts between the Division of Behavioral Health and the University of Washington (UW) and the University of Alaska Anchorage (UAA). Grantees are not required to establish contractual agreements with UW or UAA. Instead, grantees will participate in planning, training, coaching, and fidelity activities provided through these agreements. The Division will confirm each agency’s appropriate track assignment based on proposal content, readiness indicators, and identified technical assistance needs.
Readiness Definition
For the purposes of this program, readiness refers to an agency’s current capacity to implement CM with structured support. This includes having basic clinical staffing, supervisory structure, documentation systems, and organizational stability necessary to participate in CM training, planning, and implementation activities. The Division uses readiness information only to determine the appropriate technical assistance pathway for each agency.
Agencies that demonstrate higher readiness for immediate CM implementation will receive technical assistance from the University of Washington (UW), which focuses on implementation, coaching, and fidelity monitoring. Agencies that need additional preparation time will receive technical assistance from the University of Alaska Anchorage (UAA), which focuses on readiness building, foundational training, and capacity development. Readiness affects only the type of technical assistance an agency receives and does not affect eligibility for award or the amount of funding provided.
Required Program Services and Activities
CM Planning, Design, and Integration
Agencies will collaborate with the Division and technical assistance partners to design and integrate CM into their existing treatment framework. This includes identifying target behaviors, reinforcement schedules, verification methods, and establishing policies, procedures, documentation practices, and secure storage protocols that support CM implementation.
Workforce Development and Staff Training
Agencies must identify staff who will participate in CM planning, delivery, documentation, and supervision. Each agency must designate a CM Champion responsible for coordinating CM implementation activities, supporting staff adherence to CM procedures, and serving as the primary point of contact for training and technical assistance. Identified staff, including the CM Champion, will complete required CM training delivered by UW and/or UAA and will demonstrate the ability to deliver CM with fidelity using validated tools approved by the Division. Agencies must also develop onboarding processes to ensure ongoing staff competence.
Program Implementation and Service Delivery
Agencies will implement CM services that provide immediate, tangible reinforcers for verified behavioral improvements such as abstinence, consistent treatment attendance, and medication adherence. Implementation must follow evidence-based CM models and meet program, documentation, and compliance standards.
Fidelity, Quality Assurance, and Oversight
Agencies will participate in structured fidelity monitoring activities, including supervision, documentation review, periodic fidelity assessments, and ongoing consultation with UW and UAA. Agencies must maintain internal oversight systems that ensure CM is delivered consistently and with integrity.
Evaluation Participation and Reporting
Agencies will collect and submit required performance data, including CM participation, adherence, retention, treatment completion, and other indicators. Agencies must participate in evaluation activities using tools and processes approved by the Division and submit required reports according to established timelines.
Cross-Site Learning and Coordination
All funded agencies will participate in quarterly virtual meetings facilitated by the Division that support cross-site learning, peer connection, and alignment with emerging guidance and best practices in CM implementation.
Sustainability Planning
Agencies will develop sustainability strategies that support continuation of CM practices beyond the grant period. Applicants are not required to submit a full sustainability plan at the time of application. Instead, applicants must upload a one-page Sustainability Plan Narrative outlining initial ideas for sustaining CM, with the understanding that UW or UAA will support the development of a comprehensive sustainability plan during the project period.
Applicants will upload a timeline for the initiation of services and project activities. The timeline must describe the resources available to the project, outline the specific CM activities to be delivered, and clearly state the project’s anticipated goals, outputs, and outcomes in alignment with the intent of this program.
Eligibility & Compliance
The applicant must comply with all applicable federal and state protections for patient rights, including HIPAA, 42 CFR Part 2, and the Americans with Disabilities Act (ADA).
Patient Access
The applicant must develop policies and workflows that will ensure timely access to CM once implementation begins, including procedures for integrating CM into individualized treatment plans developed or approved by a licensed provider. This includes identifying strategies to support geographically accessible services (such as telehealth, satellite locations, or flexible scheduling) that will reduce barriers to participation during implementation, and ensuring grant funds are used only for services addressing opioid or stimulant misuse. If an opioid or stimulant misuse concern (current or historical) exists concurrently with other substance use, all substance use issues may be addressed. Individuals with no history of opioid or stimulant misuse are not eligible to receive services funded under this award.
Reducing Exclusion
The applicant must implement inclusive service standards that reduce barriers to care. Applicants must be responsive to all individuals, honoring diverse norms, values, beliefs, and language needs, and ensure services are accessible by offering translation or interpretation support when necessary and by adopting approaches that strengthen relationships and meet the needs of a diverse population. Applicants must prioritize populations at highest risk for overdose death, including individuals who are or have been justice-involved, those who use substances intravenously, underserved individuals, and pregnant or postpartum individuals within the first 12 months after delivery.
Applicant proposals must describe the ways in which the project aligns with program intent. The submitted project proposal will identify agency resources available to the project; describe project activities; and clearly state the project’s anticipated goals, outputs, and outcomes.
Applicants agree to comply with the following additional program requirements and service standards:
All applicants must follow 2026 Grant Programs and Service Standards (Attachment 1).
1.04Program Evaluation Requirements and Reporting
Results Based Accountability (RBA) Framework
This grant uses the Results-Based Accountability (RBA) framework to measure CM program performance and impact. RBA is a simple, common-sense approach that focuses on three core questions:
- How much did we do? (Quantity of services)
- Track the number of individuals enrolled in CM services.
- Report service encounters, CM activity type (attendance- vs. abstinence-based), incentive distribution, and participation outcomes (number completing or discontinuing CM).
- Report required SUPRT data elements.
- How well did we do it? (Quality of services)
- Assess timeliness and appropriateness of CM service delivery, including readiness, workflow, and EHR documentation.
- Track improvements in fidelity to CM models (e.g., consistent delivery, structured reinforcement schedules) supported by UW/UAA coaching.
- Report on staff training, implementation of evidence-based CM components, and integration into existing treatment.
- Is anyone better off? (Impact on client outcomes)
- By June 30, 2027, demonstrate less than or equal to ½ standard deviation improvement in client adherence and retention (30/60/90 days) compared to baseline.
- By June 30, 2027, demonstrate less than or equal to ½ standard deviation reduction in stimulant use (UDS results, engagement, completion).
- Present client-centered outcome data and/or narrative examples when applicable.
Grant Reporting
Applicants awarded funding will be expected to collect and report quantitative and qualitative data demonstrating progress in the areas defined by the RBA framework.
Performance monitoring includes:
- Documentation in AKAIMS or DBH-approved EHR
- Participation in evaluation activities aligned with the CDC Program Evaluation Framework (e.g., defining the program, collecting data, interpreting findings, and using results for improvement)
- Quarterly reporting
The applicant’s evaluation plan must incorporate the performance measures above. Applicants may propose additional measures aligned with program goals.
Required reporting will include:
- Cumulative Fiscal Reports recording overall grant and match expenditures by budget line; and
- Quarterly Program & Narrative Reports in the format prescribed by the division. These must include:
- Implementation updates
- Emerging challenges and solutions
- Progress toward CM integration and sustainability
- Attendance at required TA meetings (e.g., quarterly fidelity sessions)
- Participant data:
- Number of unique individuals receiving CM services
- Type and focus of CM services (prize-based/voucher-based, abstinence/attendance)
- Average incentive amount per participant
- Number of participants who discontinued CM services for an unplanned reason
- Number of participants who completed CM treatment
1.05Target Population and Service Area
Applicants must clearly describe the population targeted by the project, including the area or communities that will be served. Proposals will be evaluated for compatibility with the program’s intended target population identified in this solicitation.
Target Population: The target population for the solicited services includes adults (18+) with stimulant use disorders and co-occurring substance use disorders who are actively engaged in treatment services at selected provider sites. These individuals may benefit from Contingency Management (CM) interventions to support treatment adherence, retention, and overall recovery outcomes.
Service Areas and Communities: The service areas and communities requested for the services solicited are statewide, with priority given to treatment providers demonstrating capacity to integrate CM into existing services. Resource allocation will consider provider readiness and community need, including areas with higher prevalence of stimulant use and treatment demand.
1.06Program Funding
Funds available for this program are anticipated to total $125,000 during the initial 6-month budget period (February 18 – June 30, 2026), or approximately $31,250 per agency.
In Fiscal Year 2027 (July 1, 2026–June 30, 2027), program funding will increase to $175,000 total (roughly $43,750 per agency). This increase is based on the expectation of expanded service delivery, including growth in CM enrollments, improved treatment retention, stronger completion outcomes, and enhanced evaluation and fidelity monitoring capacity.
Match Requirement: The budget must include matching funds equal to 25.00% of the proposed Department funds. Calculate required match with the following formula.
Total Requested Grant Award x Required Match Percentage = Required Match
Federal grant funds may not be used to match federal funds awarded through this grant program, and State grant funds may not be used to match State funds awarded through this grant program.
Eligible sources of matching funds include:
- Local Cash: local sources, including local tax receipts, municipal revenue sharing, cash donations
- Local In-Kind: donated items of value for which the applicant incurs no cost, including volunteer labor and donations of supplies, equipment, space
- Other Sources: government and non-government grant awards, third party receipts, direct receipts such as gaming or sales of goods
- Grant Income: earnings anticipated as a result of this project proposal receiving award, and Medicaid reimbursements if award of this grant is required for the applicant to bill Medicaid for awarded services
- Medicaid: includes Medicaid which is not Grant Income, as well as other third-party receipts
Proposed Budget: The applicant must submit a budget proposal for the first partial fiscal year of the project. The proposed budget detail and narrative, including required match, will support the program's results-based service delivery and staffing requirements stated in this RFP.
Funding must be used for:
- CM participant incentives and necessary supplies to reinforce positive behavioral changes (prize items, or vouchers). Incentives must align with SAMHSA’s CM guidance and will be subject to DBH approval.
- A CM Champion (approximately 0.07–0.10 FTE, based on an estimated $7,500 annual allocation) will dedicate an estimated 2.5–4 hours per week to overseeing CM program implementation, fidelity monitoring, and coordination with UW technical assistance (TA).
- Staff training and organizational development activities to support the integration and sustainability of CM. Depending on site readiness, this may include direct implementation training and fidelity monitoring, or readiness-focused activities such as workforce development, supervision structures, documentation systems, policy development, and evaluation preparation.
- Urine analysis (UA) testing necessary to support CM fidelity when not billable to Medicaid (including when appeals for additional coverage are denied) or other payers.
Funding Restrictions:
The following restrictions apply as outlined by the SAMHSA:
- Food may be included as a necessary expense for participants receiving SAMHSA-funded mental and/or substance use disorder prevention, harm reduction, treatment, and recovery support services, not to exceed $10.00 per person per day.
- Funds may not be used to make direct payments to individuals to enter treatment or continue to participate in prevention or treatment services (See 42 U.S.C. 1320a-7b).
Recipients must also comply with SAMHSAs Standards for Financial Management and Standard Funding Restrictions in Section H of the Application Guide. Grantees may not:
- Pay for promotional items including, but not limited to, clothing and commemorative items, such as pens, mugs/cups, folders/folios, lanyards, and conference bags. (45 CFR 75.421(e)(3))
- Purchase, procure, or distribute pipes or cylindrical objects intended to be used to smoke or inhale illegal scheduled substances.
- Pay for housing other than recovery housing, which includes application fees and security deposits.
- General Provisions under Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act Public Law 117-328, Consolidated Appropriations Act, 2023, Division H, Title V, Section 526, notwithstanding any other provision of this Act, no funds appropriated in this Act shall be used to purchase sterile needles or syringes for the hypodermic injection of any illegal drug. Provided, that such limitation does not apply to the use of funds for elements of a program other than making such purchases if the relevant state or local health department, in consultation with the Centers for Disease Control and Prevention, determines that the state or local jurisdiction, as applicable, is experiencing, or is at risk for, a significant increase in hepatitis infections or an HIV outbreak due to injection drug use, and such program is operating in accordance with state and local law.
- Salary Limitation: Congress limits the direct salary for individuals under all federal grant and cooperative agreement awards not to exceed Executive Level II pay. The Executive Level II pay amount is an individual’s base salary exclusive of fringe and any income that an individual may be permitted to earn outside of the duties to your organization. The salary limitation does not apply to consultants 38 but does apply to subrecipients under a SAMHSA award or cooperative agreement. Note that these or other salary limitations will apply in future fiscal years, as required by law. The current salary limitation can be found in the most recent SAMHSA Standard Terms and Conditions.
SAMHSA Unified Performance Reporting Tool (SUPRT) Data Collection Incentives
Sub-recipients may provide non-cash incentives valued at up to $30 per individual for participation in required SUPRT follow-up interviews. Incentives may be offered for each completed follow-up interview to support federal reporting compliance. Allowable amounts are set by SAMHSA and may change if updated funding or policy guidance is issued.
Contingency Management (CM) Limitations
CM participants may not receive more than $750 in total contingencies per budget period to ensure compliance with funding limitations. Participants may not be enrolled in more than one program offering CM incentives at the same time. These guidelines ensure the integrity of incentive-based treatment approaches and promote the fair and equitable distribution of resources.
The proposed budget will be fully compliant with the limitations described in this RFP, and those detailed in 7 AAC 78.160 (Costs). Regulations are provided under the GEMS Documents tab.
Resources specific to budgeting are also available under the GEMS Documents tab. The Department's Grant Budget Preparation Guidelines provide information and guidance about budget lines, cost detail groupings, and narrative requirements. Grantee User Manual Part I provides detailed instructions for entering a budget proposal in the chapter "Responding to a Solicitation."
Other Agency Funding: Prior to submitting a proposal, applicants are required to list all other agency funding received and applied for. This task must be completed by an Agency Power User in the Other Funding section of the Agency Administration tab. This is part of the pre-award risk assessment required under Uniform Guidance 2 CFR 200.
Indirect Costs: If the proposed budget includes indirect costs, 7 AAC 78.160(p) requires a copy of the agency's current federally approved Indirect Cost Rate Agreement. The agreement is to be uploaded in the Agency Administration tab. Lapsed agreements can be used if uploaded with the negotiating federal agency's written approval to continue using the rate until a new agreement is negotiated. If an agency has never entered into a federally approved Indirect Cost Rate Agreement or no longer has a federally approved agreement in place, the recently updated Federal Uniform Guidance 2 CFR 200 now allows that agency to budget the 15% De Minimis.
Payment for Services/Grant Income: If applicable to the services proposed in response to this solicitation, awarded grantees will have a Medicaid Provider Number or apply to obtain one, and will make reasonable effort to bill all eligible services to Medicaid and any other available sources of payment before seeking grant support for delivery of the proposed services. Department funds are the payer of last resort.
In the applicant’s proposed budget, anticipated receipts and expenditures for all grant income must be evident in the detail and narrative. Fiscal reports for awarded income generating projects will include the receipts and expenditure of all grant income.